The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The Prodrug Approach: A Successful Tool for Improving Drug Solubility
Open accessAbstract
Prodrug design is a widely known molecular modification strategy that aims to optimize the physicochemical and pharmacological properties of drugs to improve their solubility and pharmacokinetic features and decrease their toxicity. A lack of solubility is one of the main obstacles to drug development. This review aims to describe recent advances in the improvement of solubility via the prodrug approach. The main chemical carriers and examples of successful strategies will be discussed, highlighting the advances of this field in the last ten years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review of the biology of quercetin and related bioflavonoids
Formica, J. V., & Regelson, W. (1995) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00077-1 · Cited by 1,765
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Basic principles of photodynamic therapy
MACDONALD, I. J., & DOUGHERTY, T. J. (2001) · Journal of Porphyrins and Phthalocyanines · doi:10.1002/jpp.328 · Cited by 1,396
Histone Deacetylase Inhibitors: Overview and Perspectives
Dokmanovic, M., Clarke, C., & Marks, P. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0324 · Cited by 1,164
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice
Pan, M.-H., Huang, T.-M., & Lin, J.-K. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15211-7 · Cited by 946
The role of glutathione in cancer
Balendiran, G. K., Dabur, R., & Fraser, D. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 927
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Prodrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
Parker, R. A., Pearce, B. C., Clark, R. W., Gordon, D. A., & Wright, J. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82115-9 · Cited by 436
Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance
Lee, S., Kim, S. M., & Lee, R. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4322 · Cited by 433
Prodrugs of Phosphates and Phosphonates
Hecker, S. J., & Erion, M. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701260b · Cited by 414
Involvement of the β-diketone moiety in the antioxidative Mechanism of Tetrahydrocurcumin
Sugiyama, Y., Kawakishi, S., & Osawa, T. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00302-4 · Cited by 385
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Pharmacokinetics of acyclovir after intravenous and oral administration
de Miranda, P., & Blum, M. R. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_b.29 · Cited by 381
Beaumont, K., Webster, R., Gardner, I., & Dack, K. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489253 · Cited by 363
Histone deacetylase inhibitors
Monneret, C. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.001 · Cited by 338
Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)
Qureshi, A., Qureshi, N., Wright, J. J. K., Shen, Z., Kramer, G., Gapor, A., Chong, Y., DeWitt, G., Ong, A. S. H., Peterson, D., et al. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.4.1021s · Cited by 316
Transport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2
Sugawara, M., Huang, W., Fei, Y., Leibach, F. H., Ganapathy, V., & Ganapathy, M. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200006)89:6<781::aid-jps10>3.0.co;2-7 · Cited by 312
Han, H.-K., de Vrueh, R. L. A., Rhie, J. K., Covitz, K.-M. Y., Smith, P. L., Lee, C.-P., Oh, D.-M., Sadee, W., & Amidon1, G. L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919319810 · Cited by 297
Targeted prodrug design to optimize drug delivery
Han, H.-K., & Amidon, G. L. (2000) · AAPS PharmSci · doi:10.1208/ps020106 · Cited by 277
Adenosine A 2A Receptor as a Drug Discovery Target
de Lera Ruiz, M., Lim, Y.-H., & Zheng, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011669 · Cited by 276
Drug Carrier for Photodynamic Cancer Therapy
Debele, T., Peng, S., & Tsai, H.-C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922094 · Cited by 239
Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogs
Wani, M. C., Ronman, P. E., Lindley, J. T., & Wall, M. E. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00179a016 · Cited by 234
Prodrugs of biologically active phosphate esters
Schultz, C. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00552-7 · Cited by 216
Response of hypercholesterolemic subjects to administration of tocotrienols
Qureshi, A. A., Bradlow, B. A., Brace, L., Manganello, J., Peterson, D. M., Pearce, B. C., Wright, J. J. K., Gapor, A., & Elson, C. E. (1995) · Lipids · doi:10.1007/bf02536620 · Cited by 206
Bone-targeting macromolecular therapeutics
WANG, D., MILLER, S., KOPECKOVA, P., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.011 · Cited by 203
Recent studies on the biofunctions and biotransformations of curcumin
Lin, J., Pan, M., & Lin‐Shiau, S. (2000) · BioFactors · doi:10.1002/biof.5520130125 · Cited by 197
Zhou, G.-B., Kang, H., Wang, L., Gao, L., Liu, P., Xie, J., Zhang, F.-X., Weng, X.-Q., Shen, Z.-X., Chen, J., et al. (2007) · Blood · doi:10.1182/blood-2006-06-032250 · Cited by 196
Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier
Wiemer, A. J., & Wiemer, D. F. (2014) · Topics in Current Chemistry · doi:10.1007/128_2014_561 · Cited by 178
Kamat, J. P., & Devasagayam, T. P. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11812-b · Cited by 158
Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams, J. D., Flora, K. P., Goldspiel, B. R., Wilson, J., Arbuck, S. G., & Finley, R. W. (1993) · PubMed · Cited by 157
Qureshi, A. A., Bradlow, B. A., Salser, W. A., & Brace, L. D. (1997) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(97)89667-2 · Cited by 147
Li, C., Wang, E.-Q., Cheng, Y., & Bao, J. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.020 · Cited by 147
Ishikawa, T., Matsunaga, N., TAWADA, H., Kuroda, N., Nakayama, Y., Ishibashi, Y., TOMIMOTO, M., Ikeda, Y., Tagawa, Y., Iizawa, Y., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00126-3 · Cited by 147
Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility
Müller, C. E. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900114 · Cited by 146
Hockemeyer, J., Burbiel, J. C., & Müller, C. E. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo0358574 · Cited by 141
Shah, S. J., & Sylvester, P. W. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000402 · Cited by 124
Sauer, R., Maurinš, J. A., Reith, U., Fülle, F., Klotz, K., & Müller, C. E. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911480 · Cited by 121
Hochdörffer, K., Ajaj, K. A., Schäfer-Obodozie, C., & Kratz, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300493m · Cited by 116
Flanagan, S., Bartizal, K. F., Minassian, S. L., Fang, E., & Prokocimer, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00431-13 · Cited by 108
Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
Hachet‐Haas, M., Balabanian, K., Rohmer, F., Pons, F., Franchet, C., Lecat, S., Chow, K. Y. C., Dagher, R., Gizzi, P., Didier, B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803947200 · Cited by 107
Nesaretnam, K., Ambra, R., Selvaduray, K. R., Radhakrishnan, A. K., Reimann, K., Razak, G. A., & Virgili, F. (2004) · Lipids · doi:10.1007/s11745-004-1251-1 · Cited by 100
Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps
Testa, B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.620 · Cited by 98
Satchi‐Fainaro, R., Hailu, H., Davies, J. W., Summerford, C., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020091k · Cited by 94
Tedizolid Phosphate: a Next-Generation Oxazolidinone
Rybak, J. M., & Roberts, K. D. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0060-3 · Cited by 89
Noguchi, M., Skwarczyński, M., Prakash, H., Hirota, S., Kimura, T., Hayashi, Y., & Kiso, Y. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.022 · Cited by 78
Progress in the Development of Selective Inhibitors of Aurora Kinases
Mortlock, A. A., Keen, N., Jung, F. H., Heron, N. M., Foote, K. M., Wilkinson, R. W., & Green, S. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054637719 · Cited by 77
Halen, P. K., Murumkar, P. R., Giridhar, R., & Yadav, M. R. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001695 · Cited by 73
Cao, F., Jia, J., Yin, Z. Q., Gao, Y., Sha, L., Lai, Y., Ping, Q., & Zhang, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200447r · Cited by 70
Moktan, S., Ryppa, C., Kratz, F., & Raucher, D. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9560-x · Cited by 69
Prodrugs for the Treatment of Neglected Diseases
Chung, M. C., Ferreira, E. I., dos Santos, J. L., Giarolla, J., Rando, D. G. G., de Almeida, A. E., Bosquesi, P. L., Menegon, R. F., & Blau, L. (2008) · Molecules · doi:10.3390/molecules13030616 · Cited by 68
Self-citationLeu, Y.-L., Chen, C., Wu, Y.-J., & Chern, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701151c · Cited by 67
Newaz, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00022-9 · Cited by 65
In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs
Montenegro, L., Carbone, C., Maniscalco, C., Lambusta, D., Nicolosi, G., Ventura, C. A., & Puglisi, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.003 · Cited by 65
Selective drug delivery to bone using acidic oligopeptides
Ishizaki, J., Waki, Y., Nishioka, T., Yokogawa, K., & Miyamoto, K. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0004-z · Cited by 55
Selective Water-Soluble Gelatinase Inhibitor Prodrugs
Gooyit, M., Lee, M., Schroeder, V. A., Ikejiri, M., Suckow, M. A., Mobashery, S., & Chang, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200566e · Cited by 54
Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles
Kim, S.-H., Markovitz, B., Trovato, R., Murphy, B. R., Austin, H., Willardsen, A. J., Baichwal, V. R., Morham, S. G., & Bajji, A. C. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.075 · Cited by 54
EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828
Binderup, E., Björkling, F., Hjarnaa, P. V., Latini, S., Baltzer, B., Carlsen, M., & Binderup, L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.064 · Cited by 51
Aspartic acid nucleates the apatite crystallites of bone: a hypothesis
Sarig, S. (2004) · Bone · doi:10.1016/j.bone.2004.02.020 · Cited by 49
Kaul, M., Mark, L., Zhang, Y., Parhi, A. K., LaVoie, E. J., & Pilch, D. S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.010 · Cited by 49
Effect of either Gamma-Tocotrienol or a Tocotrienol Mixture on the Plasma Lipid Profile in Hamsters
Raederstorff, D., Elste, V., Aebischer, C. P., & Weber, P. (2002) · Annals of Nutrition and Metabolism · doi:10.1159/000046748 · Cited by 47
Ullah, N., Huang, Z., Sanaee, F., Rodriguez-Dimitrescu, A., Aldawsari, F. S., Jamali, F., Bhardwaj, A., Islam, N. U., & Velázquez‐Martínez, C. A. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1088840 · Cited by 38
Gasparik, V., Daubeuf, F., Hachet‐Haas, M., Rohmer, F., Gizzi, P., Haiech, J., Galzi, J., Hibert, M., Bonnet, D., & Frossard, N. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200017d · Cited by 34
Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates
Shen, J., Zhang, D., Zhao, Z., Jia, L., Zheng, D., Liu, G., Hao, L., Zhang, Q., Tian, X., Li, C., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.014 · Cited by 33
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury
Lee, M., Chen, Z., Tomlinson, B. N., Gooyit, M., Hesek, D., Juárez, M. R., Nizam, R., Boggess, B., Lastochkin, E., Schroeder, V. A., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00140 · Cited by 27
O’Dowd, H., Shannon, D. E., Chandupatla, K. R., Dixit, V. S., Engtrakul, J. J., Ye, Z., Jones, S. M., O’Brien, C., Nicolau, D. P., Tessier, P. R., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00196 · Cited by 21
Enhanced efficacy of 7-hydroxy-3-methoxycadalene via glycosylation in in vivo xenograft study
Lee, H. Y., Kwon, J., Koh, M., Cho, M., & Park, S. B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.071 · Cited by 18
A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis
Flores-Ramos, M., Ibarra‐Velarde, F., Hernández‐Campos, A., Vera‐Montenegro, Y., Jung-Cook, H. H., Cantó-Alarcón, G. J., del Rivero, L. M., & Castillo, R. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.017 · Cited by 18
Akaho, N., Takata, J., Fukushima, T., Matsunaga, K., Hattori, A., Hidaka, R., Fukui, K., Yoshida, M., Fujioka, T., Karube, Y., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014365 · Cited by 13
Tang, X., Zhang, P., Ye, H., Zhang, C., Shen, W.-B., & Ping, Q. (2008) · Die Pharmazie · doi:10.31083/ph.2008.8571 · Cited by 11
Cited by
Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine
Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,649
Molecular photoswitches in aqueous environments
Volarić, J., Szymanski, W., Simeth, N. A., & Feringa, B. L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00547a · Cited by 438
Chalcone Derivatives: Promising Starting Points for Drug Design
Gomes, M., Muratov, E., Pereira, M., Peixoto, J., Rosseto, L., Cravo, P., Andrade, C., & Neves, B. (2017) · Molecules · doi:10.3390/molecules22081210 · Cited by 418
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 397
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems
Shahdadi Sardo, H., Saremnejad, F., Bagheri, S., Akhgari, A., Afrasiabi Garekani, H., & Sadeghi, F. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.022 · Cited by 126
Metadata
- Authors
- Jornada, D., Dos Santos Fernandes, G., Chiba, D., De Melo, T., Dos Santos, J., & Chung, M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2015-12-29
- Volume
- 21
- Issue
- 1
- Pages
- 42
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2213042592
- Cited by
- 294
- References
- 75
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.